🔎 Trials Near Me

Gara Jalqabaatti › Dukkana Tract Biliary › New York

Qorannoo klinikaalii Dukkana Tract Biliary New York keessatti

Qorannoo 15 Dukkana Tract Biliary f New York keessatti hirmaatuu jiru.

Magaalota New York keessatti

Takkalaa qorannoo (Ingiliffa)

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

  • Research Site, Commack
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06219941

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

  • Rosewell Park Comprehensive Cancer Center (Site 114), Buffalo
  • Memorial Sloan Kettering Cancer Center (Site 108), New York
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07265674

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

  • Research Site, Mineola
  • Research Site, New York
  • Research Site, New York
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07221253

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0327), Mineola
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 0324), New York
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06428409

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

  • Research Site, Commack
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT05489211

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

  • Memorial Sloan Kettering Cancer Centers, New York
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06282575

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT06293898

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

  • Avenzo Therapeutics Recruiting Site, New York
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07038343

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

  • Roswell Park Comprehensive Cancer Center, Buffalo
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT06774963

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

  • Research Site, White Plains
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT06467357

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • NYU Langone Health, New York
  • Icahn School of Medicine At Mount Sinai Prime, New York
  • Clinical Research Alliance, Inc, Westbury
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT06330064

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Columbia University Irving Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 8 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT05503797

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

  • Memorial Sloan Kettering Cancer Center, New York
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 16 fi ol · Saalaa hunda · Haaromfame 02-Wax-2026 · NCT07197554

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • Montefiore Medical CenterMontefiore Medical Park, The Bronx
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Elb-2026 · NCT05733598

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

  • NYU Langone, New York
  • Memorial Sloan Kettering Cancer Center, New York
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Bit-2026 · NCT04900818

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.